checkAd

     121  0 Kommentare Spectral Medical Announces Publication of Tigris Trial Methods Paper and Simulation of Results - Seite 3

    The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this statement.

    Lesen Sie auch

    For further information, please contact:

    Ali Mahdavi David Waldman/Natalya Rudman Blair McInnis
    Capital Markets & Investor Relations US Investor Relations CFO
    Spinnaker Capital Markets Inc. Crescendo Communications, LLC Spectral Medical Inc.
    416-962-3300 212-671-1020 416-626-3233
    am@spinnakercmi.com edt@crescendo-ir.com bmcinnis@spectraldx.com

    Seite 3 von 3



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Spectral Medical Announces Publication of Tigris Trial Methods Paper and Simulation of Results - Seite 3 Tomlinson et al. Bayesian methods: a potential path forward for sepsis trials. Critical Care (2023) 27:432TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company …